leukemia GMAT专八

1.battling with leukemia

同血病进斗争

2.He was diagnosed with leukemia.

他经诊断患有血病。

3.In acute lymphocytic leukemia, monoblastic leukemia as well as aplastic anemia, however...

此外,还讨论了影响实验有关因素以及与其他方法比较等。

4.The stem cell leukemia( SCL) gene is a new oncogene related with leukemogenesis.

干细胞血病(CL)因是新发现与血病发生有关因。

5.No patients developed retinoblastoma metastasis, pinealoblastoma, secondary tumor (leukemia), dysfunction of hepatic, renal or auditory.

无一例发生血病，肝肾功能及听力损害等严重化疗毒反应者。

6.In six cases of chronic myelocytic leukemia, 4 cases had MSI in more than 3 loci.

6例慢粒细胞血病中4例患者在3个以上位点有MSI；

7.Objective: To investigate the effects of curcumin on human acute myelocytic leukemia cells in vitro.

目:研究姜黄素在体外对原代血病细胞抑制作用。

8.Results showed the delation of P16 were high in ALL in 36 cases of leukemia patients.

结果36例血病中以急淋巴细胞血病（ALL）P16缺失表达率最高。

9.A case of Candida tropicalis arthritis of knee occurred in a patient with acute monocytic leukemia was reported during the recovery phase of post chemotherapy myelosuppression and agranulocytosis.

本文报告一例急单核细胞血病患者化疗后骨髓抑制和外周血粒细胞缺乏期间并发膝关节炎。

10.10例患者均未发生血病、肝肾功能及听力损害等严重化学治疗毒反应。

None of 10 patients had serious side effects of chemotheraoy like leukemia, functional damage of liver and kidney, and dysacousia.

11.Abstract Objective:To study the correlation between cytotoxicity of daunorubicine (DNR) and harringtonine (H) to leukemic cells in vitro from 39 patients with acute myeloblastic leukemia (AML).

摘要 目：化疗药物对急髓血病细胞体外毒进相关研究。

12.Immunotoxin BL22 for hairy cell leukemia.131I Antibody BC8 for acute leukemia and myelodysplastic syndrome (MDS).

免疫毒素BL22，用于毛细胞血病。碘-131标记抗体BC8，用于急血病和骨髓增生异常综合征。

13.Donor-cell leukemia after allogeneic hematopoietic stem cell transplantation can be an ideal model to investigate the related events in human leukemogenesis.

异因造血干细胞移植后供者源复发可能是研究人血病发生适宜模式。

14.Objective: To observe the clinical effects of leukapheresis plus chemotherapy on hyperleur, ocytic acute leukemia (HLAL).

摘要目：观察细胞分离术联合化疗治疗高细胞急血病(HLAL)疗效。

15.METHODS:Leukemic cells from patients with acute leukemia were treated with different antileukemic agents in microwell liquid culture,then the cytotoxicity was measured with MTT assay.

方法：将血病细胞与化疗药物微孔液体培养，MTT法检测细胞毒。

16.Objective:To study the changes of hemostatic molecular markers inacute monoblastic leukemia (AML-M5) for elucidate the mechanism of hemorrhage and its clinical significance.

目：观察急单核血病（AML-M5）止凝血因子标志物变化，探索AML-M5患者出血机制及这些标志物在疾病诊疗、预后判断中意义。

17.Its the curative effect and mechanism of action were the hot spot.The active effect have been made on the study of the therapeutics about leukemia, especially acute premyelocyte leukemia.

结论：复方黄黛研究既有延续，又有广泛，其临床疗效与作用机制是研究热点，对血病，尤其是急早幼粒细胞血病治疗学研究产生了积极影响。

18.So far, XMRV, known fully as xenotropic murine leukemia virus-related virus, doesn't appear to replicate as quickly as HIV does.

迄今为止，全称异嗜小鼠血病病毒相关病毒(Xenotropicmurineleukemiavirus-relatedvirus)XMRV病毒复制速度似乎不像艾滋病毒那么快。